Você procurou por: intużat (Maltês - Inglês)

intużat il- verżjoni 1- 7 ta ’
the 1-7 version of the panss

intużat istopatoloġija mill-istudju pivitali.
histopathology from the pivotal study was used.

ma tkunx intużat għal pagamenti intermedji; jew
it has not been used for making intermediate payments; or

intużat profilassi ta’ rutina minn żewġ individwi.
routine prophylaxis was used by two subjects.

intużat il-verżjoni 1-7 ta’ panss.
the 1-7 version of the panss was used.

ma tkunx intużat għal għanijiet ta’ prefinanzjament; jew
it has not been used for the purpose of pre-financing; or

nitrometanu: intużat mill-eta u possibilment gruppi oħra.
nitromethane: used by eta and possibly other groupings.

intużat dejta ta’ monitoraġġ disponibbli minn attivitajiet differenti.
monitoring data available from the different activities was used.

kienet intużat bħala pajjiż analogu fl-investigazzjoni preċedenti;
it was used as an analogue country in the previous investigation;

fi studji kliniċi li saru intużat doża ta ’ 600 mg amprenavir darbtejn
ritonavir: the auc and cmin of amprenavir were increased by 64% and 508% respectively and the cmax decreased by 30% when ritonavir (100 mg twice daily) was co-administered with amprenavir capsule (600 mg twice daily) compared to values achieved after 1200 mg twice daily doses of amprenavir capsules.

kwalukwe soluzzjoni fil-kunjetti li ma tkunx intużat għandha tintrema.
any unused solution in the vials must be discarded.

armi kull fdal tas-soluzzjoni li ma tkunx intużat b’mod xieraq.
discard unused solution appropriately.

fi provi kliniċi, intużat biss salina għat-tindif tal-widnejn.
in clinical trials, saline only was used for ear cleaning.

fi studji kliniċi b’chondrocelect intużat falda periosteali bħala membrana bijoloġika.
in clinical studies with chondrocelect a periosteal flap was used as a biological membrane.

kull fdal tas-soluzzjoni li ma tkunx intużat għandha tintrema b’mod xieraq.
any unused solution must be discarded appropriately.

fil-maġġoranza tal-każi, intużat rata ta’ infużjoni sa 4 ml kull minuta.
in most of the cases, an infusion rate of up to 4 ml per minute has been used.

din l-istima intużat fil-formolazzjoni tal-prijoritajiet għas-sħubija kurrenti.
this assessment has been used in formulating the priorities for the current partnership.

fil- maġġoranza tal- każi, rata ta ’ infużjoni sa ’ 4 ml kull minuta intużat.
4 4.3 contraindications

fi studju wieħed (n=157), fejn intużat doża fissa ta ’ 6 mg ta ’
in one study (n=157), which used a 6mg fixed dose of pegfilgrastim the mean duration of grade 4 neutropenia for the pegfilgrastim group was 1.8 days compared with 1.6 days in the filgrastim group (difference 0.23 days, 95% ci -0.15, 0.63).

fi studju wieħed (n=157), fejn intużat doża fissa ta ’ 6 mg ta ’ i
in a second study (n=310), which used a weight-adjusted dose (100 microgramsg/ kg), the mean duration of grade 4 neutropenia for the pegfilgrastim group was 1.7